Concepedia

Micheline Heinrich

MH

Statistics

Publications

9

Citations

1.4K

H-Index

9

Active since

1985

Affiliations

Novartis (Switzerland)(Current)

Micheline Heinrich is an author at Novartis (Switzerland) specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

1985–2002

9

Publications

9

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

F. Gasparini, Kurt Lingenhöhl, Natacha Stoehr et al. · Neuropharmacology · 1999 · 720 citations

, , +7

The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors

Adriana Pagano, Doris Rüegg, Stephane Litschig et al. · Journal of Biological Chemistry · 2000 · 267 citations · Full text

The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors

Serge Bischoff, Micheline Heinrich, Jean Marie Sonntag et al. · European Journal of Pharmacology · 1986 · 245 citations

, , +9

[3H]-M-MPEP, a Potent, Subtype-Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5

F. Gasparini, Hendrik Andres, Peter J. Flor et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 79 citations · Full text

, , +9

Interaction of the D<sub>1</sub>Receptor Antagonist Sch 23390 with the Central 5-HT System: Radioligang Binding Studies, Measurements of Biochemical Parameters and Effects on L-5-HTP Syndrome

Serge Bischoff, Micheline Heinrich, J. Krauss et al. · Journal of Receptor Research · 1988 · 46 citations

Rows per page

1–5 of 9